Journal of Medicinal Chemistry (6) von Pawel-Rammingen, U.; Johansson, B. P.; Björck, L. IdeS, a novel streptococcal cysteine proteinase with unique specificity for immunoglobulin G. EMBO J. 2002, 21, 1607−1615. (7) Wenig, K.; Chatwell, L.; von Pawel-Rammingen, U.; Björck, L.; Huber, R.; Sondermann, P. Structure of the streptococcal endopeptidase IdeS, a cysteine proteinase with strict specificity for IgG. Proc. Natl. Acad. Sci. U.S.A. 2004, 101, 17371−17376. (8) Agniswamy, J.; Nagiec, M. J.; Liu, M. Y.; Schuck, P.; Musser, J. M.; Sun, P. D. Crystal structure of group A Streptococcus Mac-1: insight into dimer-mediated specificity for recognition of human IgG. Structure 2006, 14, 225−235. (9) Kagawa, T. F.; Cooney, J. C.; Baker, H. M.; McSweeney, S.; Liu, M. Y.; Gubba, S.; Musser, J. M.; Baker, E. N. Crystal structure of the zymogen form of the group A Streptococcus virulence factor SpeB: An integrin-binding cysteine protease. Proc. Natl. Acad. Sci. U.S.A. 2000, 97, 2235−2240. (10) Olsen, J. G.; Dagil, R.; Niclasen, L. M.; Sørensen, O. E.; Kragelund, B. B. Structure of the mature streptococcal cysteine protease exotoxin mSpeB in its active dimeric form. J. Mol. Biol. 2009, 393, 693−703. (11) Collin, M.; Olseń, A. Effect of SpeB and EndoS from Streptococcus pyogenes on human immunoglobulins. Infect. Immun. 2001, 69, 7187−7189. (12) Vincents, B.; von Pawel-Rammingen, U.; Björck, L.; Abrahamson, M. Enzymatic characterization of the streptococcal endopeptidase, IdeS, reveals that it is a cysteine protease with strict specificity for IgG cleavage due to exosite binding. Biochemistry 2004, 43, 15540−15549. (13) Burton, D. R. Immunoglobulin-Gfunctional sites. Mol. Immunol. 1985, 22, 161−206. (14) Rasmussen, M.; Björck, L. Proteolysis and its regulation at the surface of Streptococcus pyogenes. Mol. Microbiol. 2002, 43, 537−544. (15) Agniswamy, J.; Lei, B. F.; Musser, J. M.; Sun, P. D. Insight of host immune evasion mediated by two variants of group A Streptococcus Mac protein. J. Biol. Chem. 2004, 279, 52789−52796. (16) Potempa, J.; Dubin, A.; Korzus, G.; Travis, J. Degradation of elastin by a cysteine proteinase from Staphylococcus aureus. J. Biol. Chem. 1988, 263, 2664−2667. (17) Johansson, B. P.; Shannon, O.; Björck, L. Ides: A bacterial proteolytic enzyme with therapeutic potential. PLoS ONE 2008, 3, e1692. (18) Nandakumar, K. S.; Johansson, B. P.; Björck, L.; Holmdahl, R. Blocking of experimental arthritis by cleavage of IgG antibodies in vivo. Arthritis Rheum. 2007, 56, 3253−3260. (19) Yang, R.; Otten, M. A.; Hellmark, T.; Collin, M.; Björck, L.; Zhao, M.-H.; Daha, M. R.; Segelmark, M. Successful treatment of experimental glomerulonephritis with IdeS and EndoS, IgG-degrading streptococcal enzymes. Nephrol., Dial., Transplant. 2010, 25, 2479− 2486. (20) Berggren, K.; Johansson, B.; Fex, T.; Kihlberg, J.; Björck, L.; Luthman, K. Synthesis and biological evaluation of reversible inhibitors of IdeS, a bacterial cysteine protease and virulence determinant. Bioorg. Med. Chem. 2009, 17, 3463−3470. (21) Filira, F.; Biondi, L.; Gobbo, M.; Rocchi, R. N-Alkylation of amino acids during hydrogenolytic deprotection. Tetrahedron Lett. 1991, 32, 7463−7464. (22) Hamid, M.; Slatford, P. A.; Williams, J. M. J. Borrowing hydrogen in the activation of alcohols. Adv. Synth. Catalysis 2007, 349, 1555−1575. (23) Berggren, K.; et al., unpublished results. (24) The peptides were purchased from CASLO Laboratory ApS, Lyngby, Denmark. (25) Åkesson, P.; Moritz, L.; Truedsson, M.; Christensson, B.; von Pawel-Rammingen, U. IdeS, a highly specific immunoglobulin G (IgG)-cleaving enzyme from Streptococcus pyogenes, is inhibited by specific IgG antibodies generated during infection. Infect. Immun. 2006, 74, 497−503. Article (26) Hopkins, A. L.; Groom, C. R.; Alex, A. Ligand efficiency: a useful metric for lead selection. Drug Discovery Today 2004, 9, 430− 431. (27) Wan, H.; Holmeń, A. G.; Wang, Y. D.; Lindberg, W.; Englund, M.; Nag̊ar̊d, M. B.; Thompson, R. A. High-throughput screening of pKa values of pharmaceuticals by pressure-assisted capillary electro- phoresis and mass spectrometry. Rapid Commun. Mass Spectrom. 2003, 17, 2639−2648. (28) Meloun, M.; Bordovska, S. Benchmarking and validating algorithms that estimate pK(a) values of drugs based on their molecular structures. Analyt. Bioanalyt. Chem. 2007, 389, 1267−1281. (29) Bogomolovas, J.; Simon, B.; Sattler, M.; Stier, G. Screening of fusion partners for high yield expression and purification of bioactive viscotoxins. Protein Expression Purif. 2009, 64, 16−23. (30) North, M. J. Cysteine endopeptidases of parasitic protozoa. Methods Enzymol. 1994, 523−539. (31) Nyberg, P.; Rasmussen, M.; von Pawel-Rammingen, U.; Björck, L. SpeB modulates fibronectin-dependent internalization of Strepto- coccus pyogenes by efficient proteolysis of cell-wall-anchored protein F1. Microbiology 2004, 150, 1559−1569. 2560 dx.doi.org/10.1021/jm201517a | J. Med. Chem. 2012, 55, 2549−2560